Skip to content
ClinCalc Pro
Menu
Antispasmodic with Antifoaming Agent (Fixed-Dose Combination)

Alverine Citrate with Simeticone

Brand names: Audmonal

This is a fixed-dose combination of alverine citrate, an antispasmodic, with simeticone, an antifoaming agent, used for symptomatic relief of irritable bowel syndrome, particularly abdominal pain and bloating.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Alverine acts directly on intestinal smooth muscle to relieve spasm, while simeticone lowers the surface tension of gas bubbles in the gut to reduce trapped wind and bloating.

Prescribing in practice

  • It should not be used where paralytic ileus or intestinal obstruction is suspected, as relieving smooth-muscle tone could be harmful in these situations.
  • Reassess any patient whose abdominal symptoms change in character or who develops alarm features, since IBS remains a diagnosis of exclusion.
  • It is intended for functional symptom relief and is generally well tolerated, but discontinue if hypersensitivity occurs.

Monitoring

No specific laboratory monitoring is required; review symptom control and reconsider the diagnosis if symptoms persist or escalate.

Counselling the patient

  • Take to relieve cramping abdominal pain and bloating associated with IBS.
  • Seek review if you notice bleeding, weight loss, or a persistent change in bowel habit.
  • Stop and seek advice if you develop a rash or other allergic reaction.

Evidence & guidelines

NICE guidance on irritable bowel syndrome supports antispasmodics for abdominal pain and spasm, alongside dietary and lifestyle measures.

Reference: NICE CKS IBS (2023); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.